Investigational Site Number : 6430007

Tyumen 625000

0 studies enrolling now · 3 studies all time

What they study most

Primary Progressive Multiple Sclerosis, Relapsing Multiple Sclerosis

Studies at this site

• Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS) — Completed
• Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple Sclerosis — Completed
• Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis — Completed